Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Oncology Progress》 2009-02
Add to Favorite Get Latest Update

Clinical application of recombinant human endostatin

Li Lixia~# Zheng Jihua Zhang Weimin Department of Oncology,Guangzhou General Hospital of PLA,Guangzhou 510010,China  
Recombinant human endostatin(RHE)has anti-angiogenetic effect with acceptable side effect.In treatment of advanced malignant carcinoma,RHE combined with or without chemotherapy can enhance treatment effect,improve quality of life,and prolong survival.
【CateGory Index】: R96
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 6 Hits
1 WANG Jinwan, SUN Yan, LIU Yongyu, YU Qitao, ZHANG Yiping, LI Kai, ZHU Yunzhong, ZHOU Qinghua, HOU Mei, GUAN Zhongzhen, LI Weilian, ZHUANG Wu, WANG Donglin, LIANG Houjie, QIN Fengzhan, LU Huishan, LIU Xiaoqing, SUN Hong, ZHANG Yanjun, WANG Jiejun, LUO Suxia, YANG Ruihe, TU Yuanrong, WANG Xiuwen, SONG Shuping, ZHOU Jingmin, YOU Lifen, WANG Jing, YAO Chen.  Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, P.R.China;Results of randomized, multicenter, double-blind phase Ⅲ trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients[J];Chinese Journal of Lung Cancer;2005-04
2 HUANG Guosheng.Department of Thoracic Surgery,Affiliated Hospital of Nanyang Medical School,Nanyang 473058,Henan;The efficacy of NP plus ENDOSTAR and chemotherapy in the treatment of non-small sell lung cancer[J];Henan Journal of Surgery;2007-06
3 Song Ziyan,Bian Baoxiang,Yang Chengxi(Department of Medical Oncology,the First People's Hospital of Lianyungang,Lianyungang 222002,China);Observation of Short-Term Effects of YH-16 Combined with GP Regimen for Non-Small Cell Lung Cancer[J];Journal of Basic and Clinical Oncology;2007-06
4 ;1例肾透明细胞癌术后肺肝转移应用恩度与Tarceva联合治疗的护理[J];Journal of Clinical Nursing;2007-01
5 LIU Xiu-feng,QIN Shu-kui,WANG Lin,QIAN Jun,CHEN Ying-xia,HE Ze-ming,GONG Xin-lei,YANG Liu-qing.Department of Medical Oncology,PLA Cancer Center,81 Hospital of PLA,Nanjing 210002,China;Endostar combined with chemotherapy on the multiple kinds of advanced malignancies[J];Chinese Clinical Oncology;2007-04
6 QIN Shu-kui,LIU Xiu-feng,WANG Lin,CHEN Ying-xia,QIAN Jun,HUA Hai-qing,GONG Xin-lei,YANG Liu-qing,HE Ze-ming.Department of Medical Oncology,PLA Cancer Center,81 Hospital of PLA,Nanjing 210002,China;Clinical study of endostar combined with chemotherapy for the multiple kind of advanced malignancies except lung cancer[J];Chinese Clinical Oncology;2007-10
【Co-citations】
Chinese Journal Full-text Database 10 Hits
1 Anhui Provincial Construction Hospital,Hefei 230022,AnhuiXU Li-ping;Nursing and Observation of 10 Cases of Advanced Stage Tumor Patients Treated with Endostar[J];Journal of Anhui Health Vocational & Technical College;2008-06
2 Li Yong Zhang Xiangru Sun Yan Cancer Institute & Hospital,CAMS & PUMC,Beijing 100021,China;Advances of targeted therapy in the treatment of non-small cell lung cancer[J];Oncology Progress;2007-02
3 Yuan Xia~1 Zhang Dongsheng~1 Yuan Zhongyu~1 He Ying~2 Ma Huimin~2 Li Jun~2 Jiang Wenqi~(1#) 1 State Key Laboratory of Oncology in South China,Department of Medical Oncology,Cancer Center,Sun Yat-sen University,Guangzhou,Guangdong,510060,P.R.China 2 Huizhou Municipal Center Hospital,Huizhou,Guangdnng,516001,P.R.China;Endostar combined with chemotherapy in the treatment of HER-2 negative breast cancer[J];Oncology Progress;2007-06
4 Li Yong Sun Yan Zhang Xiangru Cancer Institute & Hospital,CAMS&PUMC,Beijing 100021,China;The andvances of tumor anti-angiogenetic therapy[J];Oncology Progress;2008-01
5 JIANG Kui,SUN Xiu-hua,YANG Xiao-yan,ZHANG Xian,ZHANG Yang(Department of Oncology,the Second Affiliated Hospital of Dalian Medical University,Dalian 116027,China);Vinorelbine and cisplatin regimein in treating elder patients with advanced non-small cell lung cancer[J];Journal of Dalian Medical University;2008-01
6 QIN Jing1, ZHANG Peng-hai1, QIAN Xin-yu1, KANG Shi-jun1, LUO Rong-cheng1, Wang Yue-gang2 1Department of Oncology, 2Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients[J];Journal of Southern Medical University;2008-06
7 SUN Yan, LIN Hongsheng, ZHU Yunzhong, FENG Jifeng, CHEN Zhengtang, LI Gongshu, ZHANG Xiangru, ZHANG Zongqi, TANG Junfang, SHI Meiqi, HAO Xuezhi, HAN Hui. *Department of Medical Oncology, Cancer Hospital/Institute, Chinese Academy of Medical Sciences & PUMC, Beijing 100021, P.R.China;A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients[J];Chinese Journal of Lung Cancer;2006-03
8 Qinghua ZHOU Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China;New Year Wishes[J];Chinese Journal of Lung Cancer;2009-01
9 Wenjing MENG, Qi GAO, Liuchun WANG, Chun HUANG, Kai LIDepartment of Pulmonary Oncology, Tianjin Medical University Tumor Institute and Hospital, Tianjin Lung Cancer Diagnosis and Treatment Centre, Tianjin 300060, China;Analysis of Cardiovascular-related Adverse Effects of Endostar Combined with Chemotherapy in 61 NSCLC Cases[J];Chinese Journal of Lung Cancer;2009-06
10 Haiyu MU,Chunyan SHEN,Yiling FENG Cancer center,The affiliated hospitalof Armed Police for Medical College,Tianjin 300162,China;Clinical Observation on the Target Therapy of Rh-Endostin,Combined with Chemotherapy in Advanced Non-Small Cell Lung Cancer[J];Chinese Journal of Lung Cancer;2009-07
【Secondary Citations】
Chinese Journal Full-text Database 5 Hits
1 ZHANG Guo feng*, WANG Yuan he, ZHANG Ming ao, WANG Qiang, LUO Yun bao, WANG Deng shan, Han Ce ran Department of General Surgery, Changzheng Hospital,Second Military Medical University, Shanghai 200003, P.R.China;Inhibition of Growth and Metastases of Human Colon Cancer Xenograft in Nude Mice by Angiogenesis Inhibitor Endostatin[J];Chinese Journal of Cancer;2002-01
2 ZHOU Zhi-Wei1,2, WAN De-Sen1,2, WANG Guo-Qiang1,2, REN Jing-Qing1,2, LU Zhen-Hai1,2, LIN Su-Xia1,3, TANG Shao-Xian1,2, YE Yan-Li1,4, CHEN Gong1,2 1. State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong Province, 510060, P. R. China 2. Department of Abdominal Surgery, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong Province, 510060, P. R. China 3. Department of Pathology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong Province, 510060, P. R. China 4. Animal Experimental Center, Sun Yat-sen University, Guangzhou, Guangdong Province, 510060, P. R. China;Inhibitory Effect of Angiogenesis Inhibitor YH-16 on Liver Metastases from Colorectal Cancer[J];Chinese Journal of Cancer;2006-07
3 WANG Jinwan, SUN Yan, LIU Yongyu, YU Qitao, ZHANG Yiping, LI Kai, ZHU Yunzhong, ZHOU Qinghua, HOU Mei, GUAN Zhongzhen, LI Weilian, ZHUANG Wu, WANG Donglin, LIANG Houjie, QIN Fengzhan, LU Huishan, LIU Xiaoqing, SUN Hong, ZHANG Yanjun, WANG Jiejun, LUO Suxia, YANG Ruihe, TU Yuanrong, WANG Xiuwen, SONG Shuping, ZHOU Jingmin, YOU Lifen, WANG Jing, YAO Chen.  Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, P.R.China;Results of randomized, multicenter, double-blind phase Ⅲ trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients[J];Chinese Journal of Lung Cancer;2005-04
4 WU Ying, ZHAO Min, YANG Li, LIU Jian, WEI Yu-quan,ZHAO Xia △. Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu 610041, China;Inhibition of Malignant Ascites with Endostatin Adenoviral Vector[J];Journal of Sichuan University (Medical Sciences Edition);2004-03
5 LIU Xiu-feng,QIN Shu-kui,WANG Lin,QIAN Jun,CHEN Ying-xia,HE Ze-ming,GONG Xin-lei,YANG Liu-qing.Department of Medical Oncology,PLA Cancer Center,81 Hospital of PLA,Nanjing 210002,China;Endostar combined with chemotherapy on the multiple kinds of advanced malignancies[J];Chinese Clinical Oncology;2007-04
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved